SMI-Ribosome inactivating protein conjugates selectively inhibit tumor cell growth

被引:9
|
作者
Roy, Saumya [1 ]
Axup, Jun Y. [1 ]
Forsyth, Jane S. [2 ]
Goswami, Rajib K. [1 ,3 ]
Hutchins, Benjamin M. [1 ]
Bajuri, Krishna M. [1 ]
Kazane, Stephanie A. [1 ,4 ]
Smider, Vaughn V. [1 ]
Felding, Brunhilde H. [2 ]
Sinha, Subhash C. [1 ,5 ]
机构
[1] Scripps Res Inst, Dept Cell & Mol Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem Physiol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA
[3] Indian Assoc Cultivat Sci, Dept Organ Chem, Kolkata, India
[4] Pfizer Inc, Ctr Therapeut Innovat, 10770 Sci Ctr Dr, San Diego, CA 92121 USA
[5] Rockefeller Univ, Lab Mol & Cellular Neurosci, 1230 York Ave, New York, NY 10065 USA
关键词
INTEGRIN; IMMUNOTOXINS; EXPRESSION;
D O I
10.1039/c7cc00745k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cell-targeting conjugates of Saporin 6, a ribosome inactivating protein (RIP), were prepared using the Saporin Ala 157 Cys mutant, a small molecule inhibitor (SMI) of integrins alpha(v)beta(3)/alpha(v)beta(5), and a potent cytotoxin, auristatin F (AF). The conjugates selectively and potently inhibited proliferation of tumor cells expressing the target integrins. We anticipate that the small molecule-RIP bioconjugate approach can be broadly applied using other small molecule drugs.
引用
收藏
页码:4234 / 4237
页数:4
相关论文
共 50 条
  • [41] NORMAL HUMAN MONOCYTES (MC) INHIBIT TUMOR-CELL GROWTH
    KING, G
    FILE, J
    GARDNER, Y
    LAUFMAN, L
    LOBUGLIO, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 208 - 208
  • [42] Isoforms of the APC tumor suppressor and their ability to inhibit cell growth and tumorigenicity
    Daniel J Carson
    Irma M Santoro
    Joanna Groden
    Oncogene, 2004, 23 : 7144 - 7148
  • [43] NORMAL HUMAN MONOCYTES (MC) INHIBIT TUMOR-CELL GROWTH
    KING, GW
    FILE, J
    GARDNER, Y
    LAUFMAN, LR
    LOBUGLIO, AF
    CLINICAL RESEARCH, 1976, 24 (04): : A586 - A586
  • [44] Isoforms of the APC tumor suppressor and their ability to inhibit cell growth and tumorigenicity
    Carson, DJ
    Santoro, IM
    Groden, J
    ONCOGENE, 2004, 23 (42) : 7144 - 7148
  • [45] Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review
    Ou Sha
    Junfei Niu
    Tzi-Bun Ng
    Eric Yu-Pang Cho
    Xiaoyuan Fu
    Wenqi Jiang
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1387 - 1393
  • [46] Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review
    Sha, Ou
    Niu, Junfei
    Ng, Tzi-Bun
    Cho, Eric Yu-Pang
    Fu, Xiaoyuan
    Jiang, Wenqi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1387 - 1393
  • [47] Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma
    Rosenberger, Leonie
    Ezquer, Marcelo
    Lillo-Vera, Fernando
    Pedraza, Paulina L.
    Ignacia Ortuzar, Maria
    Gonzalez, Paz L.
    Figueroa-Valdes, Aliosha I.
    Cuenca, Jimena
    Ezquer, Fernando
    Khoury, Maroun
    Alcayaga-Miranda, Francisca
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [48] Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma
    Leonie Rosenberger
    Marcelo Ezquer
    Fernando Lillo-Vera
    Paulina L. Pedraza
    María Ignacia Ortúzar
    Paz L. González
    Aliosha I. Figueroa-Valdés
    Jimena Cuenca
    Fernando Ezquer
    Maroun Khoury
    Francisca Alcayaga-Miranda
    Scientific Reports, 9
  • [49] A novel series of substituted indene derivatives that potently and selectively inhibit growth of tumor cells harboring mutant Ras
    Chen, Xi
    Lee, Kevin J.
    Gary, Bernard D.
    Canzoneri, Joshua C.
    Fajardo, Alexandra M.
    Sigler, Sara C.
    Ramirez-Alcantara, Veronica
    Zhu, Bing
    Piazza, Gary A.
    Keeton, Adam B.
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [50] Sensitivity of cancer cell lines to the novel non-toxic type 2 ribosome-inactivating protein nigrin b
    Muñoz, R
    Arias, Y
    Ferreras, JM
    Jiménez, P
    Rojo, MA
    Girbés, T
    CANCER LETTERS, 2001, 167 (02) : 163 - 169